We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
Read MoreHide Full Article
In the latest trading session, UnitedHealth Group (UNH - Free Report) closed at $475.87, marking a +0.03% move from the previous day. The stock outpaced the S&P 500's daily loss of 0.24%. Elsewhere, the Dow lost 0.49%, while the tech-heavy Nasdaq lost 0.04%.
Coming into today, shares of the largest U.S. health insurer had gained 2.08% in the past month. In that same time, the Medical sector gained 2.6%, while the S&P 500 gained 0.73%.
Investors will be hoping for strength from UnitedHealth Group as it approaches its next earnings release. On that day, UnitedHealth Group is projected to report earnings of $5.39 per share, which would represent year-over-year growth of 1.51%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $78.56 billion, up 11.92% from the year-ago period.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $21.70 per share and revenue of $319.27 billion. These totals would mark changes of +14.09% and +11.01%, respectively, from last year.
Any recent changes to analyst estimates for UnitedHealth Group should also be noted by investors. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. UnitedHealth Group is holding a Zacks Rank of #3 (Hold) right now.
Looking at its valuation, UnitedHealth Group is holding a Forward P/E ratio of 21.93. This represents a premium compared to its industry's average Forward P/E of 17.99.
Investors should also note that UNH has a PEG ratio of 1.49 right now. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - HMOs industry currently had an average PEG ratio of 1.26 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 172, putting it in the bottom 33% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
In the latest trading session, UnitedHealth Group (UNH - Free Report) closed at $475.87, marking a +0.03% move from the previous day. The stock outpaced the S&P 500's daily loss of 0.24%. Elsewhere, the Dow lost 0.49%, while the tech-heavy Nasdaq lost 0.04%.
Coming into today, shares of the largest U.S. health insurer had gained 2.08% in the past month. In that same time, the Medical sector gained 2.6%, while the S&P 500 gained 0.73%.
Investors will be hoping for strength from UnitedHealth Group as it approaches its next earnings release. On that day, UnitedHealth Group is projected to report earnings of $5.39 per share, which would represent year-over-year growth of 1.51%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $78.56 billion, up 11.92% from the year-ago period.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $21.70 per share and revenue of $319.27 billion. These totals would mark changes of +14.09% and +11.01%, respectively, from last year.
Any recent changes to analyst estimates for UnitedHealth Group should also be noted by investors. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. UnitedHealth Group is holding a Zacks Rank of #3 (Hold) right now.
Looking at its valuation, UnitedHealth Group is holding a Forward P/E ratio of 21.93. This represents a premium compared to its industry's average Forward P/E of 17.99.
Investors should also note that UNH has a PEG ratio of 1.49 right now. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - HMOs industry currently had an average PEG ratio of 1.26 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. This group has a Zacks Industry Rank of 172, putting it in the bottom 33% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.